leupeptin has been researched along with indomethacin in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (53.85) | 18.7374 |
1990's | 3 (23.08) | 18.2507 |
2000's | 2 (15.38) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (7.69) | 2.80 |
Authors | Studies |
---|---|
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Fukushima, T; Sasaki, H; Sekizawa, K; Takishima, T; Yamauchi, K; Yamaya, M; Zayasu, K | 1 |
Chiyotani, A; Horii, S; Isono, K; Kanemura, T; Kobayashi, K; Sakai, N; Takeuchi, S; Takizawa, T; Tamaoki, J; Yamawaki, I | 1 |
Lapetina, EG; Ruggiero, M | 3 |
Lehmann, A | 1 |
Fischer, JE; Hasselgren, PO; Hummel, RP; James, JH; Warner, BW | 1 |
Odessey, R | 1 |
Ireland, ME; Treisman, GJ; Welsh, MJ | 1 |
Böhm, SK; Bunnett, NW; Caughey, GH; Corvera, CU; Déry, O; Khitin, LM; McConalogue, K; Payan, DG | 1 |
Rubinstein, I | 1 |
Gao, XP; Potempa, J; Rubinstein, I; Travis, J | 1 |
13 other study(ies) available for leupeptin and indomethacin
Article | Year |
---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Opsonized zymosan decreases cytoplasmic motility of alveolar macrophages in dogs.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Aminopeptidases; Animals; Calcium; Captopril; Cells, Cultured; Cytoplasm; Dogs; Indomethacin; Leucine; Leupeptins; Macrophages; Phagocytosis; Pulmonary Alveoli; Superoxide Dismutase; Zymosan | 1992 |
Atrial natriuretic factor inhibits ciliary motility in cultured rabbit tracheal epithelium.
Topics: Animals; Atrial Natriuretic Factor; Captopril; Cells, Cultured; Cilia; Enzyme Inhibitors; Epithelium; Glycopeptides; Indomethacin; Kinetics; Leucine; Leupeptins; Male; Masoprocol; Methylene Blue; Movement; Piroxicam; Purinones; Rabbits; Thiorphan; Trachea | 1991 |
Antipain or leupeptin in combination with aspirin or indomethacin synergistically inhibit human platelet activation by thrombin and trypsin.
Topics: Antipain; Aspirin; Blood Platelets; Drug Synergism; Humans; In Vitro Techniques; Indomethacin; Leupeptins; Oligopeptides; Thrombin; Trypsin | 1987 |
Pharmacological protection against the toxicity of N-methyl-D-aspartate in immature rat cerebellar slices.
Topics: Animals; Aspartic Acid; Aspirin; Calcium Channel Blockers; Cerebellum; Female; In Vitro Techniques; Indomethacin; Kynurenic Acid; Leupeptins; Male; N-Methylaspartate; Rats; Rats, Inbred Strains; Taurine | 1987 |
Effects of indomethacin and leupeptin on muscle cathepsin B activity and protein degradation during sepsis.
Topics: Animals; Bacterial Infections; Cathepsin B; Indomethacin; Leupeptins; Muscle Proteins; Muscles; Oligopeptides; Reference Values | 1988 |
Protease and cyclooxygenase inhibitors synergistically prevent activation of human platelets.
Topics: Blood Platelets; Collagen; Humans; In Vitro Techniques; Indomethacin; Leupeptins; Oligopeptides; Platelet Aggregation; Secretory Rate; Serotonin; Thrombin | 1986 |
Sustained proteolysis is required for human platelet activation by thrombin.
Topics: Blood Platelets; Humans; Indomethacin; Inositol; Kinetics; Leupeptins; Platelet Aggregation; Serotonin; Thrombin | 1986 |
Effect of inhibitors of proteolysis and arachidonic acid metabolism on burn-induced protein breakdown.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Burns; Hindlimb; Ibuprofen; In Vitro Techniques; Indomethacin; Leupeptins; Lysosomes; Muscles; Oligopeptides; Peptide Hydrolases; Protease Inhibitors; Proteins; Quinacrine; Rats; Rats, Inbred Strains; Tyrosine | 1985 |
Stimulation of rat Sertoli cell adenylate cyclase by germ cells in vitro.
Topics: Adenylyl Cyclases; Animals; Cell Membrane; Cells, Cultured; Enzyme Activation; Follicle Stimulating Hormone; Germ Cells; In Vitro Techniques; Indomethacin; Isoproterenol; Leupeptins; Male; Propranolol; Rats; Sertoli Cells | 1985 |
Mast cell tryptase regulates rat colonic myocytes through proteinase-activated receptor 2.
Topics: Adrenergic beta-Antagonists; Animals; Benzimidazoles; Bradykinin; Calcium; Cells, Cultured; Chymases; Colon; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Fluorescent Antibody Technique, Indirect; Gastrointestinal Motility; In Vitro Techniques; Indomethacin; Inflammation Mediators; Leupeptins; Mast Cells; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nitroprusside; Rats; Receptor, PAR-2; Receptors, Cell Surface; Serine Endopeptidases; Substance P; Tetrodotoxin; Time Factors; Trypsin; Tryptases | 1997 |
Subtilisin increases macromolecular efflux from the oral mucosa.
Topics: Animals; Aprotinin; Biphenyl Compounds; Bradykinin; Bradykinin Receptor Antagonists; Cricetinae; Cyclooxygenase Inhibitors; Cysteine Proteinase Inhibitors; Indomethacin; Leupeptins; Macromolecular Substances; Male; Mesocricetus; Mouth Mucosa; Neurokinin-1 Receptor Antagonists; Serine Proteinase Inhibitors; Subtilisin | 2000 |
Mechanisms mediating Porphyromonas gingivalis gingipain RgpA-induced oral mucosa inflammation in vivo.
Topics: Adhesins, Bacterial; Animals; Bradykinin; Capillary Permeability; Catalytic Domain; Cricetinae; Cysteine Endopeptidases; Gingipain Cysteine Endopeptidases; Hemagglutinins; Indomethacin; Leupeptins; Male; Mesocricetus; Mouth Mucosa; Periodontitis; Receptor, Bradykinin B2; Receptors, Bradykinin | 2001 |